Alemtuzumab (Campath)
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Alemtuzumab (Campath), covering 2006-07-25 to 2019-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome [Phase 2]